Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Flournoy

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Experimental Hematology|March 1, 1986
Recurrence of acute leukemia more than two years after allogeneic marrow graftingR Witherspoon, N Flournoy, E D Thomas, et al.
Transplantation Proceedings|March 1, 1981
Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantationP L Weiden, N Flournoy, J E Sanders, et al.
Tissue Antigens|October 1, 1976
An estimate of the recombination frequency between the B locus and the D locus within the major histocompatibility complexE M Mickelson, J S Petersons, N Flournoy, et al.
Annals of Internal Medicine|March 1, 1982
Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trialJ C Wade, B Newton, C McLaren, et al.
The New England Journal of Medicine|May 10, 1979
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow graftsP L Weiden, N Flournoy, E D Thomas, et al.
Biometrics|December 1, 1978
The analysis of failure times in the presence of competing risksR L Prentice, J D Kalbfleisch, A V Peterson, et al.
Annals of Internal Medicine|November 1, 1987
Risk factors for airflow obstruction in recipients of bone marrow transplantsJ G Clark, D A Schwartz, N Flournoy, et al.
The New England Journal of Medicine|April 17, 1986
Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantationR A Bowden, M Sayers, N Flournoy, et al.
Cancer Treatment Reports|July 1, 1984
Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancerJ Mortimer, R B Livingston, I J Hardesty, et al.
The Journal of Infectious Diseases|December 1, 1977
A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow graftsP E Neiman, W Reeves, G Ray, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Experimental Hematology|March 1, 1986
Recurrence of acute leukemia more than two years after allogeneic marrow graftingR Witherspoon, N Flournoy, E D Thomas, et al.
Transplantation Proceedings|March 1, 1981
Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantationP L Weiden, N Flournoy, J E Sanders, et al.
Tissue Antigens|October 1, 1976
An estimate of the recombination frequency between the B locus and the D locus within the major histocompatibility complexE M Mickelson, J S Petersons, N Flournoy, et al.
Annals of Internal Medicine|March 1, 1982
Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trialJ C Wade, B Newton, C McLaren, et al.
The New England Journal of Medicine|May 10, 1979
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow graftsP L Weiden, N Flournoy, E D Thomas, et al.
Biometrics|December 1, 1978
The analysis of failure times in the presence of competing risksR L Prentice, J D Kalbfleisch, A V Peterson, et al.
Annals of Internal Medicine|November 1, 1987
Risk factors for airflow obstruction in recipients of bone marrow transplantsJ G Clark, D A Schwartz, N Flournoy, et al.
The New England Journal of Medicine|April 17, 1986
Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantationR A Bowden, M Sayers, N Flournoy, et al.
Cancer Treatment Reports|July 1, 1984
Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancerJ Mortimer, R B Livingston, I J Hardesty, et al.
The Journal of Infectious Diseases|December 1, 1977
A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow graftsP E Neiman, W Reeves, G Ray, et al.
Pageof 6